Jae Jong Go

Title: Jae Jong Go: Innovator in Pharmaceutical Composition for Atopic Dermatitis

Introduction

Jae Jong Go is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of atopic dermatitis. His innovative work focuses on utilizing natural extracts for therapeutic purposes.

Latest Patents

Jae Jong Go holds 1 patent related to his research. His patent involves the use of Daphne genkwa extracts and a pharmaceutical composition containing fractions of these extracts or compounds as active ingredients for preventing or treating atopic dermatitis. The invention emphasizes the effectiveness of these extracts in increasing cytokine secretion in Th1 immune cells, thereby suppressing atopy in relevant models.

Career Highlights

Jae Jong Go is affiliated with the Korea Research Institute of Bioscience and Biotechnology. His work at this esteemed institution has allowed him to explore and develop innovative solutions for complex health issues. His research has the potential to significantly impact the treatment of atopic dermatitis.

Collaborations

Jae Jong Go collaborates with esteemed colleagues, including Jae Wha Kim and Kyung Seop Ahn. Their combined expertise enhances the research and development efforts within their field.

Conclusion

Jae Jong Go's contributions to pharmaceutical compositions for atopic dermatitis highlight his innovative spirit and dedication to improving health outcomes. His work exemplifies the importance of research in developing effective treatments for prevalent conditions.